| Literature DB >> 34072903 |
Tatiana N Zamay1,2, Vladimir S Prokopenko3, Sergey S Zamay4, Kirill A Lukyanenko1,2,5, Olga S Kolovskaya1,2, Vitaly A Orlov6,7, Galina S Zamay1,2, Rinat G Galeev8, Andrey A Narodov9, Anna S Kichkailo1,2.
Abstract
Magnetomechanical therapy is one of the most perspective directions in tumor microsurgery. According to the analysis of recent publications, it can be concluded that a nanoscalpel could become an instrument sufficient for cancer microsurgery. It should possess the following properties: (1) nano- or microsized; (2) affinity and specificity to the targets on tumor cells; (3) remote control. This nano- or microscalpel should include at least two components: (1) a physical nanostructure (particle, disc, plates) with the ability to transform the magnetic moment to mechanical torque; (2) a ligand-a molecule (antibody, aptamer, etc.) allowing the scalpel precisely target tumor cells. Literature analysis revealed that the most suitable nanoscalpel structures are anisotropic, magnetic micro- or nanodiscs with high-saturation magnetization and the absence of remanence, facilitating scalpel remote control via the magnetic field. Additionally, anisotropy enhances the transmigration of the discs to the tumor. To date, four types of magnetic microdiscs have been used for tumor destruction: synthetic antiferromagnetic P-SAF (perpendicular) and SAF (in-plane), vortex Py, and three-layer non-magnetic-ferromagnet-non-magnetic systems with flat quasi-dipole magnetic structures. In the current review, we discuss the biological effects of magnetic discs, the mechanisms of action, and the toxicity in alternating or rotating magnetic fields in vitro and in vivo. Based on the experimental data presented in the literature, we conclude that the targeted and remotely controlled magnetic field nanoscalpel is an effective and safe instrument for cancer therapy or theranostics.Entities:
Keywords: magnetic field; magnetomechanical therapy; microdiscs; nanodiscs; the nanoscalpel
Year: 2021 PMID: 34072903 PMCID: PMC8227103 DOI: 10.3390/nano11061459
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Schematic representation of the novel nanoscalpel device (a): binding selectively to tumor cells (b) for different applications (c) such as accurate diagnostics and targeted therapy (d).
Figure 2Magnetic discs are used to destroy tumor cells: synthetic antiferromagnetic P-SAF and SAF, vortex Py, and three-layer non-magnetic–ferromagnetic–non-magnetic systems with a flat quasi-dipole magnetic structure. P-SAF: Out-of-plane magnetic moments. Zero remanences. Under a magnetic field, the disc is magnetized with out-of-plane net magnetization. SAF: In-plane magnetic moments. Zero remanences. Under a magnetic field, the disc is magnetized with in-plane net magnetization. Vortex Py: In-plane magnetic moments. Zero remanences. Under a magnetic field, the disc is magnetized with in-plane net magnetization. Discs with a flat quasi-dipole magnetic structure: In-plane magnetic moments. Zero remanences. Under a magnetic field, the disc is magnetized with in-plane net magnetization.
The biological effect of magnetic antiferromagnetic (SAF and P-SAF) and vortex Py nano- and microdiscs and discs with a flat quasi-dipole magnetic structure.
| Size | Disc Type | Composition | Magnetic Field Characteristics | Biological Effect In Vitro | Reference |
|---|---|---|---|---|---|
| 2 μm | P-SAF | CoFeB connected by Pt/Ru/Pt spacers | Rotating magnetic field, 10 kOe | Destruction of 62% of U87 cells | [ |
| 2 μm | Py | Ni80Fe20 | Rotating magnetic field, 10 kOe | Destruction of 12% U87 cells | [ |
| 150/200/350 nm | Py | Ni80Fe20 | Alternating magnetic field, 20 HzDuration 2 h | Destruction of 83.4/83.2/82.5% of HeLa cells | [ |
| 2 μm | P-SAF | (Ta/Pt/CoFeB/Pt/Ru/ | Rotating magnetic field, 1 T | Destruction of 70% of U87 cells | [ |
| 1.3 μm | Py | Ni80Fe20 | Rotating magnetic field, ∼20–30 mT, 20 Hz | Destruction of 70% of renal cancer cells | [ |
| 1 μm | Py | Ni80Fe20 | Rotating magnetic field, 9 mT 20 Hz | Destruction of 90% of human glioma tumor cell line No. 10 cells ( | [ |
| 2 μm | Py | Ni80Fe20 | Rotating magnetic field 1 T, 20 Hz, | Destruction of 60% of U87 cells. | [ |
| 0.14 μm | Py | Ni80Fe20 | Rotating magnetic field | Destruction of 60% of cells | [ |
| 2 μm | Py | Ni80Fe20 | Rotating magnetic field | Destruction of 12% of cells | [ |
| 1 μm | Discs with a flat quasi-dipole magnetic structure | Au/Ni/Au | Rotating magnetic field, 50 Hz | Destruction of 80% of Ehrlich ascites adenocarcinoma cell | [ |
| 1 μm | Discs with a flat quasi-dipole magnetic structure | Au/Ni/Au | Alternating magnetic field, 50 Hz, 5 mT | Destruction of 90% of Ehrlich ascites adenocarcinoma cell | [ |
Figure 3The biological effects of magnetic nano- or microdiscs functionalized by recognizing molecules, which in the low-frequency magnetic field act inside the cell after internalization by endocytosis (a) or directly influence the cellular membrane by interacting with membrane proteins (b), causing apoptosis (c) or necrosis (d).
Figure 4Schematic diagram showing changes of the target cell’s functional state under the influence of magnetic discs and the effects on membrane proteins in an alternating or rotating magnetic field. In a magnetic field, the discs’ forces act on the cell membrane and cytoskeleton in two ways: directly (a) or indirectly through the target protein (b).
Figure 5Tumor vasculature (a) in a complex tumor microenvironment (transformed and immune cells) (b). Transport of magnetic anisotropic discs and spherical magnetic nanoparticles along transformed tumor vessels (c). Spherical particles move in the central part of the vascular bed, while anisotropic magnetic discs move along the periphery of the vessel, frequently interacting with the vessel wall; this peculiarity facilitates discs transmigration into the tumor (c). Magnetic nanodiscs are able to pass into a tumor through the damaged basal membrane in two ways: through endothelial cells and the gaps between them (d).
The biological effects of magnetic discs functionalized with antibodies and aptamers.
| Disc Type | Recognizing Agent | Disc Binding to Recognizing Agent | Cell Type; Destruction Rate | Reference |
|---|---|---|---|---|
| The 60-nm-thick, ~1-μm-diameter 20:80% iron–nickel (permalloy) discs, coated with a 5-nm-thick layer of gold on each side | Antibodies | S–Au bond | Human glioma | [ |
| The 60-nm-thick, ~1-μm-diameter 20:80% iron–nickel (permalloy) discs | Antibody antihCA9 | S–Au bond | Renal SCRC-59 renal cancer line; 90% (in vitro) | [ |
| Discs with a flat quasi-dipole magnetic structure | Aptamer | S–Au bond | Ehrlich ascites adenocarcinoma cell line; 80% (in vitro, in vivo) | [ |
| Discs with a flat quasi-dipole magnetic structure | Aptamer | S–Au bond | Ehrlich ascites adenocarcinoma cell line; | [ |